Philip Worboys Net Worth & Insider Trades
Philip Worboys - SVP, Theravance Biopharma, Inc
What is Philip Worboys's Net Worth?
The current estimated net worth of Theravance Biopharma, Inc's SVP, Philip Worboys, is estimated to be about $4.82M . Philip Worboys owns about 343,679 units of Theravance Biopharma, Inc common stock. In the last 5 years at Theravance Biopharma, Inc, Philip Worboys has sold an estimated value of $3.95M worth.
What is Philip Worboys's Past Insider Trading?
Philip Worboys's largest sale order was 21,907 units , worth over $395.38K on August 24, 2020. In total, Philip Worboys has made about 31 transactions over 5 years of their time at Theravance Biopharma, Inc. Philip Worboys usually trades in February, with the busiest year in 2018. The most recent transaction was a sale order of 8,829 units , worth over $176.58K on March 11, 2021.
PHILIP WORBOYS
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Philip Worboys's' Mailing Address?
- Mailing address is 901 Gateway Blvd South San Francisco CA 94080 CA
Theravance Biopharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Rick E Winningham | 2020 | $1,014,455 | - | $579,646 | - | $579,646 | $6,045 | $6,577,746 |
| Rick E Winningham | 2019 | $983,710 | - | $473,906 | - | $473,906 | $5,496 | $5,932,411 |
| Rick E Winningham | 2018 | $956,600 | $74,767 | $690,154 | - | $690,154 | $5,000 | $2,522,841 |
| Andrew A. Hindman | 2020 | $551,608 | - | $265,278 | - | $265,278 | $5,920 | $2,097,950 |
| Andrew A. Hindman | 2019 | $315,000 | $175,000 | $216,000 | $2,204,956 | $216,000 | - | $3,757,956 |
| Brett Haumann | 2020 | $572,569 | - | $213,589 | - | $213,589 | $53,267 | $2,742,625 |
| Brett Haumann | 2019 | $543,047 | - | $170,000 | - | $170,000 | $42,382 | $2,464,280 |
| Brett Haumann | 2018 | $497,810 | $34,125 | $315,000 | - | $315,000 | $414,300 | $1,517,194 |
| Vijay Sabesan | 2020 | $407,677 | - | $760,326 | - | $760,326 | $6,541 | $3,077,744 |
| Bradford J. Shafer | 2020 | $556,321 | - | $264,999 | - | $264,999 | $6,045 | $2,730,565 |
| Bradford J. Shafer | 2019 | $537,403 | - | $215,611 | - | $215,611 | $6,983 | $2,468,848 |
| Bradford J. Shafer | 2018 | $518,080 | $33,770 | $311,726 | - | $311,726 | $5,000 | $1,124,537 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm
What are Theravance Biopharma, Inc's Past Insider Trades?
Theravance Biopharma, Inc's most recent insider trade came on March 16, 2023 by Richard Graham who sold 2,323 units worth $23.97K . In the last 8 years, insiders at Theravance Biopharma, Inc have sold an estimated value of $150.56M and bought an estimated value of $26.3M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Bradford Shafer, EVP, Rick Winningham, CHIEF EXECUTIVE OFFICER, and Philip Worboys, SVP .
Theravance Biopharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||